Plunkett Research Online: Inotiv Inc

INOTIV INC (NOTV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two principal segments; Discovery and Safety Assessment (DSA) and Research Models and S.....
Inotiv Inc
Ticker: NOTV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 765 463-4527
Fax: 765 497-1102
Address: 2701 Kent Avenue
West Lafayette, IN 47906 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contract Research Services
Contract Research
Non-Clinical Drug Discovery
Non-Clinical Drug Development Services
Scientific Instruments
Software

Ranks not available
Contacts
Description
Robert LeasureCEO/Director/President
Beth TaylorCFO/Senior VP, Divisional
Gregory DavisChairman of the Board/Director
Brennan FreemanChief Accounting Officer/Controller/Vice President, Divisional
John SagartzChief Strategy Officer/Director
John BeattieCOO
Nigel BrownDirector
David LandmanDirector
Richard JohnsonDirector
R. NeffDirector
Fernanda BeraldiGeneral Counsel/Secretary
William PitchfordOther Executive Officer
Michael GarrettOther Executive Officer
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two principal segments; Discovery and Safety Assessment (DSA) and Research Models and S.....
See More

Auditor: RSM US LLP
Legal Advisor:
Financial Details Compare to Industry Averages Build Custom Table Compare Companies
$USD, In whole numbers,
except marked * or %		202220212020201920182017
Financials
    Revenue547,656,00089,605,00060,469,00043,616,00026,346,00024,242,000
    Cost of Revenue390,444,00059,449,00042,232,00030,695,00018,230,00016,545,000
    Gross Margin %28.7133.6530.1629.6230.8131.75
    R&D Expense - 405,000950,000627,000596,000465,000
    Operating Income20,251,000(5,618,000)(3,063,000)(153,000)14,0001,278,000
    Operating Margin %3.70-6.27-5.07-0.350.055.27
    SGA Expense99,086,00033,892,00020,350,00012,447,0007,506,0005,954,000
    Net Income(337,018,000)10,895,000(4,685,000)(790,000)(194,000)884,000
    Earnings Per Share-13.840.83-0.43-0.08-0.020.11
    Dividends - - - - - -
    Book Value Per Share - - - - - -
    Operating Cash Flow(5,217,000)10,746,0001,290,0001,777,0003,487,0001,236,000
    Capital Expenditure36,300,00012,472,0006,200,0006,878,0001,317,000347,000
    Free Cash Flow(41,517,000)(1,726,000)(4,910,000)(5,101,000)2,170,000889,000
Profitability
    EBITDA(273,421,000)14,070,000881,0002,573,0001,895,0002,963,000
    Return on Assets %-52.465.68-9.05-2.16-0.754.25
    Return on Equity %-144.8019.33-51.35-7.34-2.1212.90
    Net Margin %-61.5412.16-7.75-1.81-0.743.65
    Assets Turnover0.850.471.171.191.021.17
    Financial Leverage2.673.068.143.932.882.75
Brands, Divisions and Affiliates Top Salaries
Bioanalytical Systems Inc
NameTitleSalary (US$)Bonus (US$)
Robert LeasureCEO/President450,751100,000
John SagartzChief Strategy Officer322,67456,000
Beth TaylorCFO273,63556,000
Other Thoughts Corporate Culture

Apparent Female Officers or Directors:

How to access Plunkett Research data.

Plunkett Research offers affordable options for of business and industry statistics, trends analysis, reports and company analysis. This includes our award-winning Industry Almanacs, eBooks and our Plunkett Research Online data subscription service.

What data challenge can we help you solve today?

Take a Tour

Contact

Testimonials

…This volume is a comprehensive, one-stop source for researchers of all types…This almanac provides great facts and great comparisons in an easy-to-understand format. Prepare to be amazed.”

American Reference Books Annual

We could not have had a better start to our day… Your subjects and your presentation were truly outstanding: the information was fascinating, timely, informative and thought-provoking. Your insight into, and comprehension of, such a broad array of subject matters was indeed impressive. The factual information presented, coupled with your innate sense of humor, started the day on a bright note.

Dallas Parker, Mayer Brown Energy Conference

Thanks a lot for all the data! We are also happy to have you as a partner and I have really appreciated all of your updates and help.

H&M, One of the world’s largest retail apparel chains